You are here » Home » Companies » Company Overview » Suven Life Sciences Ltd

Suven Life Sciences Ltd.

BSE: 530239 Sector: Health care
NSE: SUVEN ISIN Code: INE495B01038
BSE LIVE 13:14 | 20 Nov 195.65 -1.00
(-0.51%)
OPEN

195.60

HIGH

198.50

LOW

194.70

NSE 13:01 | 20 Nov 195.40 -1.30
(-0.66%)
OPEN

197.05

HIGH

198.30

LOW

194.80

OPEN 195.60
PREVIOUS CLOSE 196.65
VOLUME 17754
52-Week high 230.00
52-Week low 155.00
P/E 19.82
Mkt Cap.(Rs cr) 2,491
Buy Price 195.00
Buy Qty 271.00
Sell Price 195.75
Sell Qty 7.00
OPEN 195.60
CLOSE 196.65
VOLUME 17754
52-Week high 230.00
52-Week low 155.00
P/E 19.82
Mkt Cap.(Rs cr) 2,491
Buy Price 195.00
Buy Qty 271.00
Sell Price 195.75
Sell Qty 7.00

Suven Life Sciences Ltd. (SUVEN) - Company History

Incorporated in Mar.'89 as a private limited company, Suven Pharmaceuticals (SPL) was converted into a public limited company in Jan.'95. It was promoted by Jasti Sudha Rani and Jasti Venkateswarlu, who is the present managing director. In Mar.'95, SPL came out with a public issue of 9.8 lac equity shares at a premium of Rs 40 aggregating Rs 4.9 cr to part-finance the company's project for the manufacture of bulk drugs and drug intermediates and meet long-term working capital requirements totalling to Rs 6.43 cr. The company manufactures bulk drugs and drug intermediates -- theophylline, caffeine, nitroso compound, cyanoacetic acid, etc. SPL has a sizeable export turnover through the export of drug intermediates to Germany, Switzerland, Israel, Europe, etc. During 1999-2000, the company has acquired a small pilot plant in Jeedimetla Industrial Estate,Hyderabad. During 2000-01, the company has registered a most remarkable record. The total sales of the company during 2000-01 has registered a growth of 71% over the previous year.The Profit After Tax(PAT) has also registered a growth of 325% over the previous year. The company has successfully achieved the re-certification of ISO 9002 during the year 2000-01. The company is planning to Modernize & Upgrade its R & D at Jeedimetla Industrial Estate.